This article has Open Peer Review reports available.
Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanoma
© The Author(s). 2017
Received: 27 July 2016
Accepted: 22 August 2017
Published: 29 August 2017
Open Peer Review reports
Pre-publication versions of this article are available by contacting email@example.com.
|27 Jul 2016||Submitted||Original manuscript|
|12 Dec 2016||Reviewed||Reviewer Report - Ryan Sullivan|
|12 Dec 2016||Reviewed||Reviewer Report - Rodabe Amaria|
|29 Dec 2016||Reviewed||Reviewer Report - Bonnie Elyssa Gould Rothberg|
|9 Jan 2017||Reviewed||Reviewer Report - Ian Watson|
|12 Apr 2017||Author responded||Author comments - Johan Falkenius|
|Resubmission - Version 2|
|12 Apr 2017||Submitted||Manuscript version 2|
|6 Jul 2017||Reviewed||Reviewer Report - Ryan Sullivan|
|6 Jul 2017||Reviewed||Reviewer Report - Bonnie Elyssa Gould Rothberg|
|10 Jul 2017||Reviewed||Reviewer Report - Ian Watson|
|9 Aug 2017||Author responded||Author comments - Johan Falkenius|
|Resubmission - Version 3|
|9 Aug 2017||Submitted||Manuscript version 3|
|18 Aug 2017||Author responded||Author comments - Johan Falkenius|
|Resubmission - Version 4|
|18 Aug 2017||Submitted||Manuscript version 4|
|22 Aug 2017||Editorially accepted|
|29 Aug 2017||Article published||10.1186/s12885-017-3577-x|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.